Company Information

CIN
Status
Date of Incorporation
23 April 2012
State / ROC
Hyderabad / ROC Hyderabad
Last Balance Sheet
31 March 2017
Last Annual Meeting
28 December 2017
Paid Up Capital
49,999,650
Authorised Capital
95,000,000

Directors

Ramamohan Davuluri Rao
Ramamohan Davuluri Rao
Director/Designated Partner
over 2 years ago
Sucheth Rao Davuluri
Sucheth Rao Davuluri
Director/Designated Partner
almost 3 years ago
Saharsh Rao Davuluri
Saharsh Rao Davuluri
Director/Designated Partner
over 13 years ago

Past Directors

Tirunelveli Padmanabhan Devarajan
Tirunelveli Padmanabhan Devarajan
Director
over 12 years ago
Viswanath Chebrol
Viswanath Chebrol
Alternate Director
almost 13 years ago

Patents

Novel Polymorph N Of Ivabradine Hydrochloride And Process For Its Preparation

This present invention relates to novel polymorph-N of Ivabradine Hydrochloride and process for its preparation.

Improved Process For The Preparation Of Aripiprazole Lauroxil

ABSTRACT The present invention relates to an improved process for the preparation of Aripiprazole Lauroxil of Formula (I).

"Improved Process For The Preparation Of Beta Polymorphic Form Of Ivabradine Hydrochloride

The present invention provides an improved process for the preparation of Beta Polymorphic form of Ivabradine Hydrochloride.

Process For The Preparation Of Apixaban Polymorphic Form N 1 With Particle Diameter D90 Greater Than 100 µm

The present invention relates to the process for the preparation of Apixaban polymorphic form N-1 of formula (I) having a particle size diameter D90 greater than100 µm using roller compaction technology.

Improved Process For Preparation Of Sugammadex Sodium

The present invention provides an improved process for the preparation of Sugammadex sodium and its purification process thereof.

Improved Process For The Preparation Of (R) 3 Chloro 2 Hydroxypropanoic Acid By Using Continuous Stirred Tank Reactors Technology

An improved process for the preparation 3-chloro-2-hydroxypropanoic acid of formula (I) by using   continuous stirring tank reactors (CSTRs) technology. The above intermediate of formula (I) is to provide industrially viable and inherently safer process with high yield and purity. The compound of formula (...

Process For The Preparation Of Brivaracetam

The present invention relates to process for the preparation of Brivaracetam having the structural formula (I). The present invention also relates to novel intermediates which are useful in the preparation of Brivaracetam.

"Process For The Preparation Of Levetiracetam"

The present invention relates to process for the preparation of Levetiracetam having the structural formula (I). The present invention also relates to process for the preparation of (S)-2-amino-butyric acid methyl ester compound of Formula (V).

Charges

0
08 August 2013
Export-import Bank Of India
30 Crore
22 November 2012
State Bank Of India
150 Crore
08 August 2013
Export-import Bank Of India
36 Crore
27 June 2014
Bank Of India
20 Crore
08 August 2013
Export-import Bank Of India
10 Crore
08 August 2013
Sbi Global Factors Limited
15 Crore
08 August 2013
Export-import Bank Of India
0
08 August 2013
Export-import Bank Of India
0
27 June 2014
Bank Of India
0
08 August 2013
Sbi Global Factors Limited
0
22 November 2012
State Bank Of India
0
08 August 2013
Export-import Bank Of India
0
08 August 2013
Export-import Bank Of India
0
08 August 2013
Export-import Bank Of India
0
27 June 2014
Bank Of India
0
08 August 2013
Sbi Global Factors Limited
0
22 November 2012
State Bank Of India
0
08 August 2013
Export-import Bank Of India
0
08 August 2013
Export-import Bank Of India
0
08 August 2013
Export-import Bank Of India
0
27 June 2014
Bank Of India
0
08 August 2013
Sbi Global Factors Limited
0
22 November 2012
State Bank Of India
0
08 August 2013
Export-import Bank Of India
0

Documents

Form INC-28-20042018-signed
Optional Attachment-(1)-13042018
Copy of court order or NCLT or CLB or order by any other competent authority.-13042018
List of share holders, debenture holders;-26022018
Approval letter for extension of AGM;-26022018
Copy of MGT-8-26022018
Form MGT-7-26022018_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-22012018
Optional Attachment-(1)-22012018
Approval letter of extension of financial year of AGM-22012018
Form AOC-4(XBRL)-22012018_signed
Letter of the charge holder stating that the amount has been satisfied-22082017
Form CHG-4-22082017_signed
CERTIFICATE OF SATISFACTION OF CHARGE-20170822
Optional Attachment-(2)-04072017
Optional Attachment-(1)-04072017
Notice of resignation;-04072017
Form DIR-12-04072017_signed
Evidence of cessation;-04072017
Proof of dispatch-30062017
Notice of resignation filed with the company-30062017
Form DIR-11-30062017_signed
Acknowledgement received from company-30062017
Form MGT-14-20062017_signed
Optional Attachment-(2)-20062017
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-20062017
Optional Attachment-(1)-20062017
Form MGT-14-17062017_signed
Optional Attachment-(1)-16062017
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-16062017